Activated invariant NKT cells regulate osteoclast development and function

Journal of Immunology

Volumn 186, Issue 5, 2011, Pages 2910-2917

  Hu, Ming ^a   Bassett, J H Duncan ^a   Danks, Lynett ^b   Howell, Peter G T ^c   Spanoudakis, Emmanouil ^d   Kotsianidis, Ioannis ^d   Boyde, Alan ^e   Williams, Graham R ^a   Horwood, Nikki ^b   Roberts, Irene A G ^a   Karadimitris, Anastasios ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD11B ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN P55; PROTEIN P75;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; BONE MINERALIZATION; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; ENZYME ACTIVATION; GRANULOCYTE; GROWTH PLATE; HISTOPATHOLOGY; INNATE IMMUNITY; MONOCYTE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; STEM CELL EXPANSION; TH1 CELL; TH2 CELL;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; DENDRITIC CELLS; DOWN-REGULATION; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; NATURAL KILLER T-CELLS; OSTEOCLASTS; RANK LIGAND; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 79952761784     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002353     Document Type: Article

References (50)

1. Brigl, M., and M. B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817-890.
2. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900.
3. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Valpha14 NKT cells in IL- 12-mediated rejection of tumors. Science 278: 1623-1626. (Pubitemid 27516281)
4. Smiley, S. T., M. H. Kaplan, and M. J. Grusby. 1997. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275: 977-979.
5. Nieuwenhuis, E. E. S., T. Matsumoto, M. Exley, R. A. Schleipman, J. Glickman, D. T. Bailey, N. Corazza, S. P. Colgan, A. B. Onderdonk, and R. S. Blumberg. 2002. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8: 588-593.
6. Fujii, S., K. Shimizu, C. Smith, L. Bonifaz, and R. M. Steinman. 2003. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198: 267-279.
7. Hermans, I. F., J. D. Silk, U. Gileadi, M. Salio, B. Mathew, G. Ritter, R. Schmidt, A. L. Harris, L. Old, and V. Cerundolo. 2003. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171: 5140-5147. (Pubitemid 37432797)
8. Kotsianidis, I., J. D. Silk, E. Spanoudakis, S. Patterson, A. Almeida, R. R. Schmidt, C. Tsatalas, G. Bourikas, V. Cerundolo, I. A. Roberts, and A. Karadimitris. 2006. Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells. Blood 107: 3138-3144.
9. Leite-de-Moraes, M. C., M. Lisbonne, A. Arnould, F. Machavoine, A. Herbelin, M. Dy, and E. Schneider. 2002. Ligand-activated natural killer T lymphocytes promptly produce IL-3 and GM-CSF in vivo: relevance to peripheral myeloid recruitment. Eur. J. Immunol. 32: 1897-1904.
10. Novack, D. V., and S. L. Teitelbaum. 2008. The osteoclast: friend or foe? Annu. Rev. Pathol. 3: 457-484.
11. Kollet, O., A. Dar, S. Shivtiel, A. Kalinkovich, K. Lapid, Y. Sztainberg, M. Tesio, R. M. Samstein, P. Goichberg, A. Spiegel, et al. 2006. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med. 12: 657-664.
12. Lymperi, S., N. Horwood, S. Marley, M. Y. Gordon, A. P. Cope, and F. Dazzi. 2008. Strontium can increase some osteoblasts without increasing hematopoietic stem cells. Blood 111: 1173-1181. (Pubitemid 351213398)
13. Lorenzo, J., M. Horowitz, and Y. Choi. 2008. Osteoimmunology: interactions of the bone and immune system. Endocr. Rev. 29: 403-440.
14. Fogg, D. K., C. Sibon, C. Miled, S. Jung, P. Aucouturier, D. R. Littman, A. Cumano, and F. Geissmann. 2006. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311: 83-87. (Pubitemid 43063063)
15. Miyamoto, T., O. Ohneda, F. Arai, K. Iwamoto, S. Okada, K. Takagi, D. M. Anderson, and T. Suda. 2001. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98: 2544-2554.
16. Rothe, J., W. Lesslauer, H. Lötscher, Y. Lang, P. Koebel, F. Köntgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364: 798-802. (Pubitemid 23261759)
17. Bassett, J. H. D., P. J. O'Shea, S. Sriskantharajah, B. Rabier, A. Boyde, P. G. T. Howell, R. E. Weiss, J. P. Roux, L. Malaval, P. Clement-Lacroix, et al. 2007. Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Mol. Endocrinol. 21: 1095-1107.
18. Bassett, J. H., A. Boyde, P. G. Howell, R. H. Bassett, T. M. Galliford, M. Archanco, H. Evans, M. A. Lawson, P. Croucher, D. L. St Germain, et al. 2010. Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proc. Natl. Acad. Sci. USA 107: 7604-7609.
19. Jacquin, C., D. E. Gran, S. K. Lee, J. A. Lorenzo, and H. L. Aguila. 2006. Identification of multiple osteoclast precursor populations in murine bone marrow. J. Bone Miner. Res. 21: 67-77.
20. Horwood, N. 2008. Lymphocyte-derived cytokines in inflammatory arthritis. Autoimmunity 41: 230-238. (Pubitemid 351454994)
21. Silk, J. D., I. F. Hermans, U. Gileadi, T. W. Chong, D. Shepherd, M. Salio, B. Mathew, R. R. Schmidt, S. J. Lunt, K. J. Williams, et al. 2004. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J. Clin. Invest. 114: 1800-1811.
22. Lee, K. A., M. H. Kang, Y. S. Lee, Y. J. Kim, D. H. Kim, H. J. Ko, and C. Y. Kang. 2008. A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity. Cell. Immunol. 251: 50-55.
23. Sato, K., A. Suematsu, K. Okamoto, A. Yamaguchi, Y. Morishita, Y. Kadono, S. Tanaka, T. Kodama, S. Akira, Y. Iwakura, et al. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203: 2673-2682.
24. Richardson, P. G., B. Barlogie, J. Berenson, S. Singhal, S. Jagannath, D. Irwin, S. V. Rajkumar, G. Srkalovic, M. Alsina, R. Alexanian, et al. 2003. A phase 2 study of bortezomib in relapsed, refractory myeloma. N. Engl. J. Med. 348: 2609-2617.
25. Lam, J., S. Takeshita, J. E. Barker, O. Kanagawa, F. P. Ross, and S. L. Teitelbaum. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106: 1481-1488.
26. Teitelbaum, S. L. 2006. Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res. Ther. 8: 201.
27. Irmler, I. M., M. Gajda, and R. Bräuer. 2007. Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J. Immunol. 179: 6228-6236.
28. Gapin, L. 2010. iNKT cell autoreactivity: what is 'self' and how is it recognized? Nat. Rev. Immunol. 10: 272-277.
29. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
30. Kollet, O., A. Dar, and T. Lapidot. 2007. The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization. Annu. Rev. Immunol. 25: 51-69.
31. Ozmen, L., M. Pericin, J. Hakimi, R. A. Chizzonite, M. Wysocka, G. Trinchieri, M. Gately, and G. Garotta. 1994. Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med. 180: 907-915.
32. Gowen, M., and G. R. Mundy. 1986. Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro. J. Immunol. 136: 2478-2482.
33. Takahashi, N., G. R. Mundy, and G. D. Roodman. 1986. Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells. J. Immunol. 137: 3544-3549.
34. Gao, Y., F. Grassi, M. R. Ryan, M. Terauchi, K. Page, X. Yang, M. N. Weitzmann, and R. Pacifici. 2007. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J. Clin. Invest. 117: 122-132.
35. Takayanagi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, A. Takaoka, T. Yokochi, H. Oda, K. Tanaka, et al. 2000. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. [gamma] Nature 408: 600-605.
36. Carnaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, and A. Bendelac. 1999. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163: 4647-4650. (Pubitemid 29501223)
37. Biburger, M., and G. Tiegs. 2005. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J. Immunol. 175: 1540-1550. (Pubitemid 41023055)
38. Abu-Amer, Y., J. Erdmann, L. Alexopoulou, G. Kollias, F. P. Ross, and S. L. Teitelbaum. 2000. Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J. Biol. Chem. 275: 27307-27310.
39. Moreno, J. L., M. Kaczmarek, A. D. Keegan, and M. Tondravi. 2003. IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. Blood 102: 1078-1086. (Pubitemid 36917809)
40. Guillot, P. V., H. T. Cook, C. D. Pusey, N. M. Fisk, S. Harten, J. Moss, I. Shore, and G. Bou-Gharios. 2008. Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type I alpha 2-deficient mouse. J. Pathol. 214: 627-636. (Pubitemid 351482278)
41. Okada, Y., I. Morimoto, K. Ura, Y. Nakano, Y. Tanaka, S. Nishida, T. Nakamura, and S. Eto. 1998. Short-term treatment of recombinant murine interleukin-4 rapidly inhibits bone formation in normal and ovariectomized mice. Bone 22: 361-365. (Pubitemid 28177189)
42. van Der Vliet, H. J. J., N. Nishi, T. D. de Gruijl, B. M. von Blomberg, A. J. M. van den Eertwegh, H. M. Pinedo, G. Giaccone, and R. J. Scheper. 2000. Human natural killer T cells acquire a memory-activated phenotype before birth. Blood 95: 2440-2442.
43. D'Andrea, A., D. Goux, C. De Lalla, Y. Koezuka, D. Montagna, A. Moretta, P. Dellabona, G. Casorati, and S. Abrignani. 2000. Neonatal invariant Valpha24+ NKT lymphocytes are activated memory cells. Eur. J. Immunol. 30: 1544-1550.
44. Walsh, M. C., N. Kim, Y. Kadono, J. Rho, S. Y. Lee, J. Lorenzo, and Y. Choi. 2006. Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol. 24: 33-63.
45. Nakashima, T., and H. Takayanagi. 2008. The dynamic interplay between osteoclasts and the immune system. Arch. Biochem. Biophys. 473: 166-171.
46. Takayanagi, H. 2005. Mechanistic insight into osteoclast differentiation in osteoimmunology. J. Mol. Med. 83: 170-179.
47. Teige, A., R. Bockermann, M. Hasan, K. E. Olofsson, Y. Liu, and S. Issazadeh- Navikas. 2010. CD1d-dependent NKT cells play a protective role in acute and chronic arthritis models by ameliorating antigen-specific Th1 responses. J. Immunol. 185: 345-356.
48. Linsen, L., M. Thewissen, K. Baeten, V. Somers, P. Geusens, J. Raus, and P. Stinissen. 2005. Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis. Arthritis Res. Ther. 7: R493-R502.
49. van Amerongen, M. J., G. Bou-Gharios, E. Popa, J. van Ark, A. H. Petersen, G. M. van Dam, M. J. van Luyn, and M. C. Harmsen. 2008. Bone marrowderived myofibroblasts contribute functionally to scar formation after myocardial infarction. J. Pathol. 214: 377-386.
50. van der Vliet, H. J. J., B. M. von Blomberg, N. Nishi, M. Reijm, A. E. Voskuyl, A. A. van Bodegraven, C. H. Polman, T. Rustemeyer, P. Lips, A. J. M. van den Eertwegh, et al. 2001. Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100: 144-148.